Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 12 2020
Historique:
received: 08 06 2018
accepted: 11 08 2020
pubmed: 14 8 2020
medline: 17 2 2021
entrez: 14 8 2020
Statut: ppublish

Résumé

Gain-of-function mutations in with no lysine (K) 1 (WNK1) and WNK4 genes are responsible for familial hyperkalemic hypertension (FHHt), a rare, inherited disorder characterized by arterial hypertension and hyperkalemia with metabolic acidosis. More recently, FHHt-causing mutations in the Kelch-like 3-Cullin 3 (KLHL3-CUL3) E3 ubiquitin ligase complex have shed light on the importance of WNK's cellular degradation on renal ion transport. Using full exome sequencing for a 4-generation family and then targeted sequencing in other suspected cases, we have identified new missense variants in the WNK1 gene clustering in the short conserved acidic motif known to interact with the KLHL3-CUL3 ubiquitin complex. Affected subjects had an early onset of a hyperkalemic hyperchloremic phenotype, but normal blood pressure values"Functional experiments in Xenopus laevis oocytes and HEK293T cells demonstrated that these mutations strongly decrease the ubiquitination of the kidney-specific isoform KS-WNK1 by the KLHL3-CUL3 complex rather than the long ubiquitous catalytically active L-WNK1 isoform. A corresponding CRISPR/Cas9 engineered mouse model recapitulated both the clinical and biological phenotypes. Renal investigations showed increased activation of the Ste20 proline alanine-rich kinase-Na+-Cl- cotransporter (SPAK-NCC) phosphorylation cascade, associated with impaired ROMK apical expression in the distal part of the renal tubule. Together, these new WNK1 genetic variants highlight the importance of the KS-WNK1 isoform abundance on potassium homeostasis.

Identifiants

pubmed: 32790646
pii: 94171
doi: 10.1172/JCI94171
pmc: PMC7685730
doi:
pii:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
CUL3 protein, human 0
Cul3 protein, mouse 0
Cullin Proteins 0
KLHL3 protein, human 0
KLHL3 protein, mouse 0
Microfilament Proteins 0
Stk39 protein, mouse EC 2.7.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1
STK39 protein, human EC 2.7.11.1
WNK Lysine-Deficient Protein Kinase 1 EC 2.7.11.1
WNK1 protein, human EC 2.7.11.1
Wnk1 protein, mouse EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6379-6394

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK054231
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK093501
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK110375
Pays : United States

Références

BMC Genet. 2005 Dec 30;6 Suppl 1:S13
pubmed: 16451588
Miner Electrolyte Metab. 1986;12(4):226-33
pubmed: 3762509
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14366-71
pubmed: 23940364
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8558-63
pubmed: 16709664
Sci Signal. 2014 May 06;7(324):ra41
pubmed: 24803536
J Am Soc Nephrol. 2006 Jan;17(1):208-17
pubmed: 16221868
Nat Biotechnol. 2009 Feb;27(2):182-9
pubmed: 19182786
Cell Metab. 2007 May;5(5):331-44
pubmed: 17488636
Am J Physiol Renal Physiol. 2006 Mar;290(3):F619-24
pubmed: 16204408
Am J Physiol Renal Physiol. 2018 Aug 1;315(2):F223-F230
pubmed: 29667910
Sci Rep. 2018 Feb 19;8(1):3249
pubmed: 29459793
Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F292-F300
pubmed: 30484345
Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F734-F745
pubmed: 29846116
Physiol Rev. 2011 Jan;91(1):177-219
pubmed: 21248166
Biochem J. 2014 Jun 1;460(2):237-46
pubmed: 24641320
J Clin Endocrinol Metab. 2004 Aug;89(8):4025-30
pubmed: 15292344
Hypertension. 2014 Nov;64(5):1047-53
pubmed: 25113964
Mol Cell Biol. 2017 Mar 17;37(7):
pubmed: 28052936
Nat Methods. 2011 Jul 17;8(9):753-5
pubmed: 21765410
J Am Soc Nephrol. 2008 Mar;19(3):424-6
pubmed: 18216310
Hum Mol Genet. 2011 Mar 1;20(5):855-66
pubmed: 21131289
Endocrine. 2008 Jun;33(3):230-4
pubmed: 19016006
Nat Med. 2012 Sep;18(9):1324-5; author reply 1325-7
pubmed: 22961153
Med Sci (Paris). 2012 Aug-Sep;28(8-9):703-6
pubmed: 22920870
J Am Soc Nephrol. 2010 Nov;21(11):1868-77
pubmed: 20813865
Science. 2001 Aug 10;293(5532):1107-12
pubmed: 11498583
Kidney Int. 1973 Apr;3(4):251-7
pubmed: 4792041
Mol Cell Biol. 2003 Dec;23(24):9208-21
pubmed: 14645531
J Biol Chem. 2003 Sep 26;278(39):37073-82
pubmed: 12871941
Biochem J. 2013 Apr 1;451(1):111-22
pubmed: 23387299
Nature. 2012 Jan 22;482(7383):98-102
pubmed: 22266938
Am J Physiol Renal Physiol. 2020 Jan 1;318(1):F216-F228
pubmed: 31736353
PLoS One. 2012;7(5):e37751
pubmed: 22701532
Nat Genet. 2006 Oct;38(10):1124-32
pubmed: 16964266
J Clin Invest. 1999 Oct;104(7):R19-23
pubmed: 10510339
J Clin Invest. 1970 Nov;49(11):2119-27
pubmed: 4319969
Nat Genet. 2002 Jan;30(1):97-101
pubmed: 11731797
Mol Biol Cell. 2018 Feb 15;29(4):499-509
pubmed: 29237822
Hypertension. 2005 Aug;46(2):295-300
pubmed: 15998707
Curr Opin Nephrol Hypertens. 2011 Sep;20(5):547-54
pubmed: 21788894
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18109-14
pubmed: 20921400
FEBS Lett. 2013 Jun 19;587(12):1717-22
pubmed: 23665031
Cell Rep. 2013 Mar 28;3(3):858-68
pubmed: 23453970
Kidney Int. 2000 Feb;57(2):607-12
pubmed: 10652038
Kidney Int. 2014 Jul;86(1):139-45
pubmed: 24573316
J Pediatr. 1997 Aug;131(2):252-7
pubmed: 9290612
Ren Fail. 2007;29(2):239-41
pubmed: 17365944
Hum Mol Genet. 2014 Oct 1;23(19):5052-60
pubmed: 24821705
Nat Genet. 2012 Mar 11;44(4):456-60, S1-3
pubmed: 22406640
J Am Soc Nephrol. 2006 Sep;17(9):2402-13
pubmed: 16899520
Am J Physiol Renal Physiol. 2012 Sep;303(5):F667-73
pubmed: 22791335
Am J Physiol Renal Physiol. 2000 Jul;279(1):F161-9
pubmed: 10894798
Am J Physiol Renal Physiol. 2014 Nov 1;307(9):F991-F1002
pubmed: 25186299
Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1048-52
pubmed: 11903313
Am J Kidney Dis. 1986 Mar;7(3):241-4
pubmed: 3953573
J Cell Sci. 2011 Mar 1;124(Pt 5):789-800
pubmed: 21321328
EMBO Mol Med. 2010 Feb;2(2):63-75
pubmed: 20091762
J Am Soc Nephrol. 2017 Sep;28(9):2597-2606
pubmed: 28442491
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7838-43
pubmed: 23576762

Auteurs

Hélène Louis-Dit-Picard (H)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.

Ilektra Kouranti (I)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.

Chloé Rafael (C)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.
INSERM UMR_S1155, Tenon Hospital, Paris, France.
Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.

Irmine Loisel-Ferreira (I)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.

Maria Chavez-Canales (M)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.
Translational Medicine Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México and Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, Mexico City, Mexico.

Waed Abdel-Khalek (W)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.

Eduardo R Argaiz (ER)

Molecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.

Stéphanie Baron (S)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.
Service d'Explorations Fonctionnelles, Assistance Publique-Hôpitaux de Paris (AP-HP), F-75015, Paris, France.

Sarah Vacle (S)

Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.

Tiffany Migeon (T)

INSERM UMR_S1155, Tenon Hospital, Paris, France.

Richard Coleman (R)

Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Marcio Do Cruzeiro (M)

NSERM U1016, Institut Cochin, Paris, France.

Marguerite Hureaux (M)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.
AP-HP, Département de Génétique, Hôpital Européen Georges Pompidou, Paris, France.

Nirubiah Thurairajasingam (N)

AP-HP, Département de Génétique, Hôpital Européen Georges Pompidou, Paris, France.

Stéphane Decramer (S)

Service de Néphrologie Pédiatrique, Hôpital des Enfants, Toulouse, France.

Xavier Girerd (X)

AP-HP, Institute of Cardiometabolism and Nutrition (ICAN), Unité de Prévention Cardiovasculaire, Hôpital de La Pitié-Salpêtrière, Paris, France.

Kevin O'Shaugnessy (K)

Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

Paolo Mulatero (P)

Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino, Italy.

Gwenaëlle Roussey (G)

Néphrologie Pédiatrique-Clinique Médicale Pédiatrique, Hôpital Mère Enfant, CHU de Nantes, Nantes, France.

Ivan Tack (I)

Service des Explorations Fonctionnelles Physiologiques, CHU de Toulouse et INSERM U1048-I2MC, Toulouse, France.

Robert Unwin (R)

UCL Department of Renal Medicine, University College London, Royal Free Campus and Hospital, London, United Kingdom.

Rosa Vargas-Poussou (R)

AP-HP, Département de Génétique, Hôpital Européen Georges Pompidou, Paris, France.

Olivier Staub (O)

Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.

Richard Grimm (R)

Departments of Medicine, Nephrology, and Physiology, Johns Hopkins University Medical School, Baltimore, Maryland, USA.

Paul A Welling (PA)

Departments of Medicine, Nephrology, and Physiology, Johns Hopkins University Medical School, Baltimore, Maryland, USA.

Gerardo Gamba (G)

Molecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.

Eric Clauser (E)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.

Juliette Hadchouel (J)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.
INSERM UMR_S1155, Tenon Hospital, Paris, France.
Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.

Xavier Jeunemaitre (X)

Université de Paris, INSERM, PARCC, F-75006, Paris, France.
AP-HP, Département de Génétique, Hôpital Européen Georges Pompidou, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH